Leukemia, Myelomonocytic, Acute - 25 Studies Found
Completed |
: Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML : Leukemia, Myelomonocytic, Acute : 2006-08-10 : Drug: XIAP antisense 2 days loading dose followed by weekly 2hr infusion |
Completed |
: Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia : Leukemia, Myelomonocytic, Acute : 2010-07-30 : Drug: Erlotinib Erlotinib will be administered orally at 150 mg once a day, continuously. Each cycle wil |
Withdrawn |
: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia :
|
Completed |
: Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia :
: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
: A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) : Leukemia, Myelomonocytic, Chronic : 2017-01-24 :
|
Recruiting |
: Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia : Leukemia, Myelomonocytic, Chronic : 2016-06-15 : Drug: Tipifarnib Oral tablet Other Names: |
Recruiting |
: Study of Lenzilumab (KB003) in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML) : Chronic Myelomonocytic Leukemia (CMML) : 2015-08-27 : Drug: lenzilumab Other Names:
|
Active, not recruiting |
: A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib : Myelomonocytic Leukemia : 2013-01-24 : Drug: Ruxolitinib In Phase I, participants will be allocated to twice a day (BID) doses of 10 mg/d up to |
Active, not recruiting |
: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2011-05-09 : Drug: Revlimid Dose escalation 5mg - 10mg - 15mg - 20mg in |
Completed |
: A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia : Chronic Myelomonocytic Leukemia : 2011-04-29 : Drug: 5-Azacitidine Administered on Days 1-7 of each Cycle |